C-Cbl-Mediated Neddylation Antagonizes Ubiquitination and Degradation of the TGF-β Type II Receptor

Molecular Cell

Volumn 49, Issue 3, 2013, Pages 499-510

  Zuo, Wei ^a   Huang, Fei ^a   Chiang, Y Jeffrey ^b   Li, Meng ^c   Du, Jun ^a   Ding, Yi ^a   Zhang, Ting ^a   Lee, Hyuk Woo ^d   Jeong, Lak Shin ^d   Chen, Yuling ^a   Deng, Haiteng ^a   Feng, Xin Hua ^e   Luo, Shiwen ^f   Gao, Chunji ^c   Chen, Ye Guang ^a  

^a TSINGHUA UNIVERSITY   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d Ewha Womans University   (South Korea)

^e ZHEJIANG UNIVERSITY   (China)

^f NANCHANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; NEDD8 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UBIQUITIN PROTEIN LIGASE E3;

ANIMAL CELL; ARTICLE; B CELL LYMPHOMA; CANCER CELL; DOWN REGULATION; EMBRYO; ENDOCYTOSIS; ENDOSOME; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; MOUSE; NEDDYLATION; NONHUMAN; PROTO ONCOGENE; UBIQUITINATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL COMPARTMENTATION; CELL MEMBRANE; EMBRYO, MAMMALIAN; FIBROBLASTS; HEK293 CELLS; HUMANS; LEUKEMIA; MICE; MOLECULAR SEQUENCE DATA; MUTATION; NIH 3T3 CELLS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA; UBIQUITINATION; UBIQUITINS;

EID: 84873438391     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2012.12.002     Document Type: Article

References (51)

1. Adams C.O., Housley W.J., Bhowmick S., Cone R.E., Rajan T.V., Forouhar F., Clark R.B. Cbl-b(-/-) T cells demonstrate in vivo resistance to regulatory T cells but a context-dependent resistance to TGF-beta. J. Immunol. 2010, 185:2051-2058.
2. Atfi A., Dumont E., Colland F., Bonnier D., L'helgoualc'h A., Prunier C., Ferrand N., Clément B., Wewer U.M., Théret N. The disintegrin and metalloproteinase ADAM12 contributes to TGF-beta signaling through interaction with the type II receptor. J. Cell Biol. 2007, 178:201-208.
3. Bianchi N., Chiarabelli C., Borgatti M., Mischiati C., Fibach E., Gambari R. Accumulation of gamma-globin mRNA and induction of erythroid differentiation after treatment of human leukaemic K562 cells with tallimustine. Br. J. Haematol. 2001, 113:951-961.
4. Chen Y.G. Endocytic regulation of TGF-beta signaling. Cell Res. 2009, 19:58-70.
5. Chiang Y.J., Sommers C.L., Jordan M.S., Gu H., Samelson L.E., Koretzky G.A., Hodes R.J. Inactivation of c-Cbl reverses neonatal lethality and T cell developmental arrest of SLP-76-deficient mice. J. Exp. Med. 2004, 200:25-34.
6. Di Guglielmo G.M., Le Roy C., Goodfellow A.F., Wrana J.L. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat. Cell Biol. 2003, 5:410-421.
7. Dong M., Blobe G.C. Role of transforming growth factor-beta in hematologic malignancies. Blood 2006, 107:4589-4596.
8. Feng X.H., Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu. Rev. Cell Dev. Biol. 2005, 21:659-693.
9. Harada Y., Harada Y., Elly C., Ying G., Paik J.H., DePinho R.A., Liu Y.C. Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J. Exp. Med. 2010, 207:1381-1391.
10. Hjerpe R., Thomas Y., Chen J., Zemla A., Curran S., Shpiro N., Dick L.R., Kurz T. Changes in the ratio of free NEDD8 to ubiquitin triggers NEDDylation by ubiquitin enzymes. Biochem. J. 2012, 441:927-936.
11. Huang A., de Jong R.N., Wienk H., Winkler G.S., Timmers H.T., Boelens R. E2-c-Cbl recognition is necessary but not sufficient for ubiquitination activity. J. Mol. Biol. 2009, 385:507-519.
12. Ikushima H., Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat. Rev. Cancer 2010, 10:415-424.
13. Joazeiro C.A., Wing S.S., Huang H., Leverson J.D., Hunter T., Liu Y.C. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 1999, 286:309-312.
14. Kales S.C., Ryan P.E., Nau M.M., Lipkowitz S. Cbl and human myeloid neoplasms: the Cbl oncogene comes of age. Cancer Res. 2010, 70:4789-4794.
15. Kamitani T., Kito K., Nguyen H.P., Yeh E.T. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J. Biol. Chem. 1997, 272:28557-28562.
16. Kang J.S., Saunier E.F., Akhurst R.J., Derynck R. The type I TGF-beta receptor is covalently modified and regulated by sumoylation. Nat. Cell Biol. 2008, 10:654-664.
17. Kang J.S., Liu C., Derynck R. New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol. 2009, 19:385-394.
18. Kang J.M., Park S., Kim S.J., Hong H.Y., Jeong J., Kim H.S., Kim S.J. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling. Oncogene 2012, 31:5123-5131.
19. Keller J.R., Mantel C., Sing G.K., Ellingsworth L.R., Ruscetti S.K., Ruscetti F.W. Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J. Exp. Med. 1988, 168:737-750.
20. Le Roy C., Wrana J.L. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat. Rev. Mol. Cell Biol. 2005, 6:112-126.
21. Lin H.K., Bergmann S., Pandolfi P.P. Deregulated TGF-beta signaling in leukemogenesis. Oncogene 2005, 24:5693-5700.
22. Lönn P., Morén A., Raja E., Dahl M., Moustakas A. Regulating the stability of TGFbeta receptors and Smads. Cell Res. 2009, 19:21-35.
23. Massagué J., Chen Y.G. Controlling TGF-beta signaling. Genes Dev. 2000, 14:627-644.
24. Mendoza H.M., Shen L.N., Botting C., Lewis A., Chen J., Ink B., Hay R.T. NEDP1, a highly conserved cysteine protease that deNEDDylates Cullins. J. Biol. Chem. 2003, 278:25637-25643.
25. Morimoto M., Nishida T., Nagayama Y., Yasuda H. Nedd8-modification of Cul1 is promoted by Roc1 as a Nedd8-E3 ligase and regulates its stability. Biochem. Biophys. Res. Commun. 2003, 301:392-398.
26. Moustakas A., Heldin C.H. The regulation of TGFbeta signal transduction. Development 2009, 136:3699-3714.
27. Naramura M., Nadeau S., Mohapatra B., Ahmad G., Mukhopadhyay C., Sattler M., Raja S.M., Natarajan A., Band V., Band H. Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders. Oncotarget 2011, 2:245-250.
28. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993, 81:2844-2853.
29. Oved S., Mosesson Y., Zwang Y., Santonico E., Shtiegman K., Marmor M.D., Kochupurakkal B.S., Katz M., Lavi S., Cesareni G., Yarden Y. Conjugation to Nedd8 instigates ubiquitylation and down-regulation of activated receptor tyrosine kinases. J. Biol. Chem. 2006, 281:21640-21651.
30. Pertovaara L., Sistonen L., Bos T.J., Vogt P.K., Keski-Oja J., Alitalo K. Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation. Mol. Cell. Biol. 1989, 9:1255-1262.
31. Quéré R., Karlsson G., Hertwig F., Rissler M., Lindqvist B., Fioretos T., Vandenberghe P., Slovak M.L., Cammenga J., Karlsson S. Smad4 binds Hoxa9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by Hoxa9 and leukemia transformation. Blood 2011, 117:5918-5930.
32. Rathinam C., Thien C.B., Langdon W.Y., Gu H., Flavell R.A. The E3 ubiquitin ligase c-Cbl restricts development and functions of hematopoietic stem cells. Genes Dev. 2008, 22:992-997.
33. Rathinam C., Thien C.B., Flavell R.A., Langdon W.Y. Myeloid leukemia development in c-Cbl RING finger mutant mice is dependent on FLT3 signaling. Cancer Cell 2010, 18:341-352.
34. Ryu J.H., Li S.H., Park H.S., Park J.W., Lee B., Chun Y.S. Hypoxia-inducible factor α subunit stabilization by NEDD8 conjugation is reactive oxygen species-dependent. J. Biol. Chem. 2011, 286:6963-6970.
35. Sanada M., Suzuki T., Shih L.Y., Otsu M., Kato M., Yamazaki S., Tamura A., Honda H., Sakata-Yanagimoto M., Kumano K., et al. Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms. Nature 2009, 460:904-908.
36. Sargin B., Choudhary C., Crosetto N., Schmidt M.H., Grundler R., Rensinghoff M., Thiessen C., Tickenbrock L., Schwäble J., Brandts C., et al. Flt3-dependent transformation by inactivating c-Cbl mutations in AML. Blood 2007, 110:1004-1012.
37. Savona M., Talpaz M. Getting to the stem of chronic myeloid leukaemia. Nat. Rev. Cancer 2008, 8:341-350.
38. Schmidt M.H., Dikic I. The Cbl interactome and its functions. Nat. Rev. Mol. Cell Biol. 2005, 6:907-918.
39. Soucy T.A., Smith P.G., Milhollen M.A., Berger A.J., Gavin J.M., Adhikari S., Brownell J.E., Burke K.E., Cardin D.P., Critchley S., et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 2009, 458:732-736.
40. Sundqvist A., Liu G., Mirsaliotis A., Xirodimas D.P. Regulation of nucleolar signalling to p53 through NEDDylation of L11. EMBO Rep. 2009, 10:1132-1139.
41. Thien C.B., Langdon W.Y. Cbl: many adaptations to regulate protein tyrosine kinases. Nat. Rev. Mol. Cell Biol. 2001, 2:294-307.
42. Wada H., Yeh E.T., Kamitani T. A dominant-negative UBC12 mutant sequesters NEDD8 and inhibits NEDD8 conjugation in vivo. J. Biol. Chem. 2000, 275:17008-17015.
43. Wang Q., Huang Z., Xue H., Jin C., Ju X.L., Han J.D., Chen Y.G. MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood 2008, 111:588-595.
44. Watson I.R., Li B.K., Roche O., Blanch A., Ohh M., Irwin M.S. Chemotherapy induces NEDP1-mediated destabilization of MDM2. Oncogene 2010, 29:297-304.
45. Watson I.R., Irwin M.S., Ohh M. NEDD8 pathways in cancer. Cancer Cell 2011, 19:168-176.
46. Wohlfert E.A., Callahan M.K., Clark R.B. Resistance to CD4+CD25+ regulatory T cells and TGF-beta in Cbl-b-/- mice. J. Immunol. 2004, 173:1059-1065.
47. Wohlfert E.A., Gorelik L., Mittler R., Flavell R.A., Clark R.B. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo. J. Immunol. 2006, 176:1316-1320.
48. Wolfraim L.A., Fernandez T.M., Mamura M., Fuller W.L., Kumar R., Cole D.E., Byfield S., Felici A., Flanders K.C., Walz T.M., et al. Loss of Smad3 in acute T-cell lymphoblastic leukemia. N. Engl. J. Med. 2004, 351:552-559.
49. Wrighton K.H., Lin X., Feng X.H. Phospho-control of TGF-beta superfamily signaling. Cell Res. 2009, 19:8-20.
50. Yamazaki S., Iwama A., Takayanagi S., Eto K., Ema H., Nakauchi H. TGF-beta as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation. Blood 2009, 113:1250-1256.
51. Zuo W., Chen Y.G. Specific activation of mitogen-activated protein kinase by transforming growth factor-beta receptors in lipid rafts is required for epithelial cell plasticity. Mol. Biol. Cell 2009, 20:1020-1029.